SCHEMBL7422905

SCHEMBL7422905

COc1ccc2c(c1)C[C@H](C)CN2

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 3/20 0.48
PDE3B Q13370 1/20 0.46
PDE3A Q14432 1/20 0.46
CHRNB2 P17787 1/20 0.46
CHRNB4 P30926 1/20 0.46
CHRNA3 P32297 1/20 0.46
CHRNA7 P36544 1/20 0.46
CHRNA4 P43681 1/20 0.46
HDAC8 Q9BY41 1/20 0.44
HTR2B P41595 2/20 0.42
HTR2A P28223 1/20 0.42
ACHE P22303 1/20 0.41
DRD2 P14416 1/20 0.41
DRD3 P35462 1/20 0.41
SLC6A4 P31645 1/20 0.39
HTR6 P50406 1/20 0.39
CYP19A1 P11511 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7419580 1.00 HTR2C (0.48) HTR2CPDE3BPDE3ACHRNB2CHRNB4
Hydrochloric Acid SCHEMBL10813428 0.81 DRD2 (0.53) HTR2CPDE3BPDE3ACHRNB2CHRNB4
SCHEMBL29073386 0.80 HDAC8 (0.50) HTR2CPDE3BPDE3ACHRNB2CHRNB4
SCHEMBL25330315 0.78 CYP19A1 (0.45) HTR2CPDE3BPDE3ACHRNB2CHRNB4
Hydrochloric Acid SCHEMBL10812978 0.78 PDE3B (0.42) HTR2CPDE3BPDE3ACHRNB2CHRNB4
SCHEMBL10262493 0.77 TRPM5 (0.37) HTR2CCHRNB2CHRNA4HTR2BHTR2A
SCHEMBL7420138 0.76 PNMT (0.45) HTR2CHTR2BHTR2A
SCHEMBL7420139 0.76 PNMT (0.45) HTR2CHTR2BHTR2A
SCHEMBL11087883 0.76 PDE3B (0.45) HTR2CPDE3BPDE3ACHRNB2CHRNB4
SCHEMBL18325378 0.75 HTR2C (0.50) HTR2CCHRNB2CHRNB4CHRNA3CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815103-A1 TRYPSIN AND THROMBIN INHIBITORS Novartis AG (CH) 1998-01-07 EP disclosed
WO-1996029327-A1 TRYPSIN AND THROMBIN INHIBITORS NOVARTIS AG (CH) 1996-09-26 WO disclosed